Kallikrein 13 Protein (AA 1-277) (GST tag)
-
- Antigène Voir toutes Kallikrein 13 (KLK13) Protéines
- Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))
- Type de proteíne
- Recombinant
- Attributs du protein
- AA 1-277
-
Origine
- Humain
-
Source
- Wheat germ
- Purification/Conjugué
- Cette Kallikrein 13 protéine est marqué à la GST tag.
- Application
- Western Blotting (WB), ELISA, Affinity Purification (AP), Antibody Array (AA)
- Fonction
- KLK13 (Human) Recombinant Protein (P01)
- Séquence
- MWPLALVIAS LTLALSGGVS QESSKVLNTN GTSGFLPGGY TCFPHSQPWQ AALLVQGRLL CGGVLVHPKW VLTAAHCLKE GLKVYLGKHA LGRVEAGEQV REVVHSIPHP EYRRSPTHLN HDHDIMLLEL QSPVQLTGYI QTLPLSHNNR LTPGTTCRVS GWGTTTSPQV NYPKTLQCAN IQLRSDEECR QVYPGKITDN MLCAGTKEGG KDSCEGDSGG PLVCNRTLYG IVSWGDFPCG QPDRPGVYTR VSRYVLWIRE TIRKYETQQQ KWLKGPQ
- Attributs du produit
- Human KLK13 full-length ORF ( NP_056411.1, 1 a.a. - 277 a.a.) recombinant protein with GST-tag at N-terminal.
- Purification
- in vitro wheat germ expression system
- Top Product
- Discover our top product KLK13 Protéine
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Commentaires
-
Preparation method: in vitro, wheat germ expression system
Product Quality tested by: 12.5% SDS-PAGE Stained with Coomassie Blue. - Restrictions
- For Research Use only
-
- Buffer
- 50 mM Tris-HCI, 10 mM reduced Glutathione, pH =8.0 in the elution buffer.
- Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
- Stock
- -80 °C
- Stockage commentaire
- Best use within three months from the date of receipt of this protein.
-
- Antigène
- Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))
- Autre désignation
- KLK13 (KLK13 Produits)
- Synonymes
- KLK-L4 Protein, KLKL4 Protein, Egfbp-2 Protein, mGk-13 Protein, kallikrein related peptidase 13 Protein, kallikrein related-peptidase 13 Protein, KLK13 Protein, Klk13 Protein
- Sujet
-
Full Gene Name: kallikrein-related peptidase 13
Synonyms: DKFZp586J1923,KLK-L4,KLKL4 - ID gène
- 26085
- NCBI Accession
- NM_015596
- Pathways
- Système du Complément
-